Published

Psilocybin Therapy for Clinicians With Symptoms of Depression From Frontline Care During the COVID-19 Pandemic: A Randomized Clinical Trial.

An abstract is available from the original source but is not redistributed by this tracker. Read the source record.

Open source BibTeX RIS

Bibliographic context

Journal: JAMA network open
Date: 2024-12-02
Source: PubMed
DOI: 10.1001/jamanetworkopen.2024.49026
PubMed: 39636638

Authors

Back AL Freeman-Young TK Morgan L Sethi T Baker KK Myers S McGregor BA Harvey K Tai M Kollefrath A Thomas BJ Sorta D Kaelen M Kelmendi B Gooley TA

Watch author

Derived topics and classifications

psilocybin Depression PTSD Clinical Trial Healthcare Workers Clinical Trial

Citation graph

0 referenced DOIs found in stored source metadata. 9 indexed papers cite this DOI.

Open citation network

Indexed papers citing this DOI

Psilocybin for Fear of Cancer Recurrence2026-08-01 Reporting practices in psilocybin-assisted therapy trials for depression: A descriptive review and temporal overview2026-07-13 Psilocybin and Mental Health Outcomes: Scoping Review with ☸️SAIMSARA2026-06-15 The magic of mushrooms: psilocybin influences behavior in the mangrove rivulus fish, Kryptolebias marmoratus2026-05-07 The efficacy and safety of psilocybin-assisted therapy for major depressive disorder: a meta-analytic review of clinical outcomes2026-04-21 A living systematic review, meta-analysis and open-data resource of randomized controlled trials of psilocybin treatment for symptoms of depression2026-04-06 Therapeutic Potential of Psilocybin in Psychiatric Disorders: Mechanisms, Efficacy, and Clinical Implications2026-04-01 Psilocybin or Nicotine Patch for Smoking Cessation2026-03-10 Psilocybin Therapy for Clinicians With Symptoms of Depression From Frontline Care During the COVID-19 Pandemic: A Randomized Clinical Trial.2024-12-02

Related papers

Effect of Psilocybin on the Positive Valence System in Treatment-resistant Depression: a Pilot Clinical Neuroimaging StudyClinicalTrials.gov · 2025-08-20 Maddening Therapies: How Hallucinogens Morphed into Novel TreatmentsCurrent psychiatry · 2017-01-01 Molecular Structure, Reactivity and Spectroscopic Properties of Hallucinogens Psilocybin, Mescaline and their Derivatives - A Computational StudyLetters in Applied NanoBioScience · 2022-09-17 Pilot Study: Effects of Psilocybin on Behavior, Psychology and Brain Function in Long-term MeditatorsClinicalTrials.gov · 2014-05-20